Synaptopathies: genetics, biophysics and circuit mechanisms of paroxysmal neurological disorders.
In plain English
AI plain-English summaryMillions of people with epilepsy, migraine, and other paroxysmal neurological disorders carry genetic variants that disrupt how their neurons communicate, but the specific genes and mechanisms remain unknown for most cases. This research addresses a fundamental gap: while rare, inherited forms of these disorders are linked to genes controlling synaptic transmission—the release and reception of chemical signals between neurons—the genetic basis of common, non-inherited forms is poorly understood. The team will sequence DNA from patients, identify candidate variants, and then test those variants in living cells and animals to see exactly how they alter synaptic function. They will also use the mutations themselves as tools to uncover basic principles of how synapses work. If successful, this work could identify new therapeutic targets for conditions that affect tens of millions of people worldwide. Because these disorders are episodic—symptoms come and go—understanding the underlying synaptic instability might eventually lead to treatments that prevent attacks rather than just manage symptoms. The project is primarily fundamental science, but similar mechanistic studies of synaptic proteins have previously led directly to drugs for epilepsy and migraine.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Strategic Award - SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know